• Odinwell received a non-binding letter of intent from a global advanced wound-care company to evaluate its optical wound-monitoring technology.
• The group will assess product performance, potential portfolio integration, and possible areas for future cooperation during the evaluation period.
• The LOI carries no exclusivity, no binding commitments, and no commercial agreement or purchase order at this stage.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Odinwell AB published the original content used to generate this news brief via Cision (Ref. ID: 202610140252BITN____UKPR__SV_20261014-BIT-3146-0) on October 14, 2026, and is solely responsible for the information contained therein.